Hazel B. Breitz
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
-
- Radiopharmaceutical Chemistry and Applications 38
- Monoclonal and Polyclonal Antibodies Research 12
- Oncology 19
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- Paul L. Weiden (14 shared papers)Darrell R. Fisher (10 shared papers)Ruby F. Meredith (7 shared papers)Michael G. Stabin (4 shared papers)Barry W. Wessels (4 shared papers)Michael L. Goris (4 shared papers)Donald B. Axworthy (3 shared papers)John M. Reno (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Biotherapy and Radiopharmaceuticals (8 papers)Blood (4 papers)Obstetrics and Gynecology (2 papers)Medical Physics (1 paper)
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Hazel B. Breitz
52 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 85
- Radiology, Nuclear Medicine and Imaging 1.1k
- Oncology 394
- Pathology and Forensic Medicine 239
- Radiation 119
- Pulmonary and Respiratory Medicine 241
Countries citing papers authored by Hazel B. Breitz
This map shows the geographic impact of Hazel B. Breitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel B. Breitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel B. Breitz more than expected).
Fields of papers citing papers by Hazel B. Breitz
This network shows the impact of papers produced by Hazel B. Breitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel B. Breitz. The network helps show where Hazel B. Breitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Hazel B. Breitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. | 2000 | 163 |
| 2 | 2008 | 133 | |
| 3 | Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. | 2000 | 125 |
| 4 | 2004 | 119 | |
| 5 | 2000 | 111 | |
| 6 | Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. | 1992 | 97 |
| 7 | 2003 | 84 | |
| 8 | 2009 | 79 | |
| 9 | 2001 | 62 | |
| 10 | Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies. | 2005 | 53 |
| 11 | Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison. | 2004 | 51 |
| 12 | 1999 | 51 | |
| 13 | 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy. | 2006 | 47 |
| 14 | 1994 | 38 | |
| 15 | 2010 | 35 | |
| 16 | Breast milk excretion of radiopharmaceuticals: mechanisms, findings, and radiation dosimetry. | 2000 | 35 |
| 17 | 2003 | 34 | |
| 18 | Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase I trials. | 1993 | 31 |
| 19 | 1997 | 30 | |
| 20 | Contribution to red marrow absorbed dose from total body activity: a correction to the MIRD method. | 2001 | 26 |
About Hazel B. Breitz
Hazel B. Breitz is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiation, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (38 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Cancer Treatment and Pharmacology (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (5 papers), Lung Cancer Research Studies (5 papers), Advanced Radiotherapy Techniques (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Oncology (394 citations), Pathology and Forensic Medicine (239 citations), Radiation (119 citations) and Pulmonary and Respiratory Medicine (241 citations). Hazel B. Breitz has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Paul L. Weiden, Darrell R. Fisher, Ruby F. Meredith, Michael G. Stabin, Barry W. Wessels, Michael L. Goris, Donald B. Axworthy, John M. Reno, M J Bjorn and Lionel G. Bouchet. Their work appears in journals such as Journal of Clinical Oncology, Cancer Biotherapy and Radiopharmaceuticals, Blood, Obstetrics and Gynecology and Medical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.